FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2039787192> ?p ?o ?g. }

• W2039787192 endingPage "7028" @default.
• W2039787192 startingPage "7025" @default.
• W2039787192 abstract "CD40 ligand (CD40L) is expressed on the surface of activated CD4+ T cells, basophils, and mast cells. Binding of C40L to its receptor, CD40, on the surface of B cells stimulates B cell proliferation, adhesion and differentiation. A preparation of soluble, recombinant CD40L (Tyr-45 to Leu-261), containing the full-length 29-kDa protein and two smaller fragments of 18 and 14 kDa, has been shown to induce differentiation of B cells derived either from normal donors or from patients with X-linked hyper-IgM syndrome (Durandy, A., Schiff, C., Bonnefoy, J.-Y., Forveille, M., Rousset, F., Mazzei, G., Milili, M., and Fischer, A. (1993) Eur. J. Immunol. 23, 2294-2299). We have now purified each of these fragments to homogeneity and show that only the 18-kDa fragment (identified as Glu-108 to Leu-261) is biologically active. When expressed in recombinant form, the 18-kDa protein exhibited full activity in B cell proliferation and differentiation assays, was able to rescue of B cells from apoptosis, and bound soluble CD40. Sucrose gradient sedimentation shows that the 18-kDa protein sediments as an apparent homotrimer, a result consistent with the proposed trimeric structure of CD40L. This demonstrates that a soluble CD40L can stimulate CD40 in a manner indistinguishable from the membrane-bound form of the protein. CD40 ligand (CD40L) is expressed on the surface of activated CD4+ T cells, basophils, and mast cells. Binding of C40L to its receptor, CD40, on the surface of B cells stimulates B cell proliferation, adhesion and differentiation. A preparation of soluble, recombinant CD40L (Tyr-45 to Leu-261), containing the full-length 29-kDa protein and two smaller fragments of 18 and 14 kDa, has been shown to induce differentiation of B cells derived either from normal donors or from patients with X-linked hyper-IgM syndrome (Durandy, A., Schiff, C., Bonnefoy, J.-Y., Forveille, M., Rousset, F., Mazzei, G., Milili, M., and Fischer, A. (1993) Eur. J. Immunol. 23, 2294-2299). We have now purified each of these fragments to homogeneity and show that only the 18-kDa fragment (identified as Glu-108 to Leu-261) is biologically active. When expressed in recombinant form, the 18-kDa protein exhibited full activity in B cell proliferation and differentiation assays, was able to rescue of B cells from apoptosis, and bound soluble CD40. Sucrose gradient sedimentation shows that the 18-kDa protein sediments as an apparent homotrimer, a result consistent with the proposed trimeric structure of CD40L. This demonstrates that a soluble CD40L can stimulate CD40 in a manner indistinguishable from the membrane-bound form of the protein." @default.
• W2039787192 created "2016-06-24" @default.
• W2039787192 creator A5010977763 @default.
• W2039787192 creator A5025155115 @default.
• W2039787192 creator A5042027146 @default.
• W2039787192 creator A5050894666 @default.
• W2039787192 creator A5055896588 @default.
• W2039787192 creator A5057662813 @default.
• W2039787192 creator A5069420951 @default.
• W2039787192 creator A5073156947 @default.
• W2039787192 creator A5081330050 @default.
• W2039787192 creator A5082225032 @default.
• W2039787192 date "1995-03-01" @default.
• W2039787192 modified "2023-10-18" @default.
• W2039787192 title "Recombinant Soluble Trimeric CD40 Ligand Is Biologically Active" @default.
• W2039787192 cites W1528551608 @default.
• W2039787192 cites W1541486667 @default.
• W2039787192 cites W1987653378 @default.
• W2039787192 cites W1989055057 @default.
• W2039787192 cites W2002162604 @default.
• W2039787192 cites W2005881684 @default.
• W2039787192 cites W2008236686 @default.
• W2039787192 cites W2009380373 @default.
• W2039787192 cites W2017472765 @default.
• W2039787192 cites W2024158949 @default.
• W2039787192 cites W2029249439 @default.
• W2039787192 cites W2048914173 @default.
• W2039787192 cites W2060382742 @default.
• W2039787192 cites W2064327582 @default.
• W2039787192 cites W2065056509 @default.
• W2039787192 cites W2069784383 @default.
• W2039787192 cites W2084701318 @default.
• W2039787192 cites W2090030418 @default.
• W2039787192 cites W2091085026 @default.
• W2039787192 cites W2091192880 @default.
• W2039787192 cites W2091227842 @default.
• W2039787192 cites W2149937387 @default.
• W2039787192 doi "https://doi.org/10.1074/jbc.270.13.7025" @default.
• W2039787192 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7706236" @default.
• W2039787192 hasPublicationYear "1995" @default.
• W2039787192 type Work @default.
• W2039787192 sameAs 2039787192 @default.
• W2039787192 citedByCount "159" @default.
• W2039787192 countsByYear W20397871922012 @default.
• W2039787192 countsByYear W20397871922013 @default.
• W2039787192 countsByYear W20397871922014 @default.
• W2039787192 countsByYear W20397871922015 @default.
• W2039787192 countsByYear W20397871922016 @default.
• W2039787192 countsByYear W20397871922017 @default.
• W2039787192 countsByYear W20397871922018 @default.
• W2039787192 countsByYear W20397871922019 @default.
• W2039787192 countsByYear W20397871922020 @default.
• W2039787192 countsByYear W20397871922021 @default.
• W2039787192 countsByYear W20397871922022 @default.
• W2039787192 crossrefType "journal-article" @default.
• W2039787192 hasAuthorship W2039787192A5010977763 @default.
• W2039787192 hasAuthorship W2039787192A5025155115 @default.
• W2039787192 hasAuthorship W2039787192A5042027146 @default.
• W2039787192 hasAuthorship W2039787192A5050894666 @default.
• W2039787192 hasAuthorship W2039787192A5055896588 @default.
• W2039787192 hasAuthorship W2039787192A5057662813 @default.
• W2039787192 hasAuthorship W2039787192A5069420951 @default.
• W2039787192 hasAuthorship W2039787192A5073156947 @default.
• W2039787192 hasAuthorship W2039787192A5081330050 @default.
• W2039787192 hasAuthorship W2039787192A5082225032 @default.
• W2039787192 hasBestOaLocation W20397871921 @default.
• W2039787192 hasConcept C104317684 @default.
• W2039787192 hasConcept C116569031 @default.
• W2039787192 hasConcept C153911025 @default.
• W2039787192 hasConcept C154317977 @default.
• W2039787192 hasConcept C170493617 @default.
• W2039787192 hasConcept C185592680 @default.
• W2039787192 hasConcept C202751555 @default.
• W2039787192 hasConcept C39347974 @default.
• W2039787192 hasConcept C40767141 @default.
• W2039787192 hasConcept C55493867 @default.
• W2039787192 hasConcept C86803240 @default.
• W2039787192 hasConceptScore W2039787192C104317684 @default.
• W2039787192 hasConceptScore W2039787192C116569031 @default.
• W2039787192 hasConceptScore W2039787192C153911025 @default.
• W2039787192 hasConceptScore W2039787192C154317977 @default.
• W2039787192 hasConceptScore W2039787192C170493617 @default.
• W2039787192 hasConceptScore W2039787192C185592680 @default.
• W2039787192 hasConceptScore W2039787192C202751555 @default.
• W2039787192 hasConceptScore W2039787192C39347974 @default.
• W2039787192 hasConceptScore W2039787192C40767141 @default.
• W2039787192 hasConceptScore W2039787192C55493867 @default.
• W2039787192 hasConceptScore W2039787192C86803240 @default.
• W2039787192 hasIssue "13" @default.
• W2039787192 hasLocation W20397871921 @default.
• W2039787192 hasOpenAccess W2039787192 @default.
• W2039787192 hasPrimaryLocation W20397871921 @default.
• W2039787192 hasRelatedWork W1496743899 @default.
• W2039787192 hasRelatedWork W1980377213 @default.
• W2039787192 hasRelatedWork W2339270935 @default.
• W2039787192 hasRelatedWork W2348822029 @default.
• W2039787192 hasRelatedWork W2356177663 @default.
• W2039787192 hasRelatedWork W2375903150 @default.

• next